Certificate number:RU.77.99.11.003.Е.006687.06.14 Date of registration and renewal:06.06.2014 Dosage form: & nbspEffervescent tablets weighing 7.8 g. Classification "Composition" & nbsp BAD - vitamin and mineral complexes Dietary supplements - polyphenolic compounds BAD - products of plant, animal or mineral origin Classification "Clinical" & nbsp BAD-sources of vitamin-mineral complexes Supplements of restorative action Supplements containing zinc, copper, manganese Supplements containing potassium and magnesium Supplements containing selenium Supplements that support the functions of the immune system Supplements that support the function of the cardiovascular system Composition: & nbspIngredients: vitamin B1, B2, B3, B6, B9, B12, C, D3, E, potassium carbonate, magnesium sulfate, zinc sulfate monohydrate, sodium selenite, ubiquinone, dry hawthorn extract, dry hearth extract, E330, sodium hydrogen carbonate , sorbitol, maltodextrin, aspartame, acesulfame potassium, flavoring orange. Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, the departments of the trade network as a biologically active food additive - an additional source of vitamins C, E, D, B1, B2, B3, B6, B12, folic acid and minerals (magnesium, zinc, selenium), a source of coenzyme Q10. Suggested Usage: & nbspAdults take 1 tablet 1 time per day with meals, previously dissolved in a glass of water. Duration of admission is 20 days.If necessary, the reception can be repeated after 1-3 months. Contraindications:Individual intolerance of components, pregnancy, lactation, phenylketonuria. Special instructions:Before use, it is recommended to consult a doctor. Shelf life:3 years. Storage conditions:Store in a dry place, protected from direct sunlight and out of reach of children, at a temperature of no higher than 25 ° C. Research protocols:Expert conclusion of the FBUF of the Federal Target Program and the Federal Service for Consumer Rights Protection No. 10-2FTS / 1866 of April 23, 2014. ManufacturersKENDI LTD Bulgaria"KENDI LTD.", Bankya, ul. Sofia №101, Community Stolichna (address of production: 2227 Bozhurishte, Gurmazovskoe highway, 8) (Bulgaria). Recipient:ROTAPHARM LIMITEDROTAPHARM LIMITED United Kingdom Information update date: & nbsp27.05.2016 Instructions